Page 2 - Clinically Relevant News Today

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ...

A new study demonstrated the efficacy of the Galanthus nivalis agglutinin (GNA)-incorporated affinity resin against various SARS-CoV-2 variants.

At the 2021 American Society of Hematology (ASH) Annual Meeting Regulatory News: OSE Immunotherapeutics SA (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) presented the first preclinical data on

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

On October 27, 2021, the U.S. Food and Drug Administration (FDA), Health Canada and the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) issued a set of ten...

Complex Regional Pain Syndrome (CRPS): A Screening & Treatment Update motor or tropic changes The updated criteria weeds out outlier diseases, added Dr. Harden. When we tried to use the Budapest criteria as an entry into research, I have to say all heck broke loose.” There have been several trials that have failed, most likely because CRPS is a multifactorial, multi-mechanism disease. So the treatments under study are not likely to produce results with a significant P value because the popul...